EV/EBITDA:
-16.80-0.43(-2.63%)Summary
- As of today (August 4, 2025), APLS EV/EBITDA is -16.80, with a fall of -0.43 (-2.63%) during the most recent trading session on August 1, 2025.
- Over the past year, APLS EV/EBITDA has dropped by -1.31 (-8.46%).
- APLS EV/EBITDA is now -367.97% below its all-time high of -3.59.
Performance
APLS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
APLS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.6% | +2.6% | +2.7% |
| 1 m1 month | -24.7% | +24.7% | +25.7% |
| 3 m3 months | -10.9% | +12.4% | +12.8% |
| 6 m6 months | +29.9% | -19.0% | -20.3% |
| ytdytd | +37.1% | -27.3% | -28.1% |
| 1 y1 year | -8.5% | -35.1% | -37.2% |
| 5 y5 years | -258.2% | +40.6% | -16.9% |
APLS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -12.88 | -30.4% | -16.80 | at low |
| 3 m | 3-month | -12.31 | -36.5% | -16.80 | at low |
| 6 m | 6-month | -12.31 | -36.5% | -25.13 | +33.1% |
| 1 y | 1-year | -12.31 | -36.5% | -28.33 | +40.7% |
| 3 y | 3-year | -3.59 | -368.0% | -28.33 | +40.7% |
| 5 y | 5-year | -3.59 | -368.0% | -28.33 | +40.7% |
| alltime | all time | -3.59 | -368.0% | -28.33 | +40.7% |
APLS EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.80(-37.1%) |
| 2024 | -26.69(+91.1%) |
| 2023 | -13.97(+63.0%) |
| 2022 | -8.57(+49.8%) |
| Date | Value |
|---|---|
| 2021 | -5.72(-57.1%) |
| 2020 | -13.34(+126.1%) |
| 2019 | -5.90(+23.7%) |
| 2018 | -4.77(-74.4%) |
| 2017 | -18.62 |
FAQ
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
- What is APLS EV/EBITDA year-to-date change?
- What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Apellis Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of APLS is -16.80
What is the all time high EV/EBITDA for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high EV/EBITDA is -3.59
What is APLS EV/EBITDA year-to-date change?
Apellis Pharmaceuticals, Inc. EV/EBITDA has changed by +9.89 (+37.06%) since the beginning of the year
What is Apellis Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, APLS EV/EBITDA has changed by -1.31 (-8.46%)